Side-by-side financials for ALLR and AZN. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ALLR | AZN |
|---|---|---|
| Market cap | - | $286.27 B |
| US-listed rank | - | #45 |
| Revenue (latest FY) | $320.00K | - |
| Net income (latest FY) | -$11.23M | - |
| Net margin | -3509.7% | - |
| SEC filings | 388 | 1,004 |
Full pages: Allarity Therapeutics, Inc. and AstraZeneca PLC, or browse the full rankings.